ATCC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ATCC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9303
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms, cell lines and other materials. Its products include nucleic acids, cells and microorganisms, testing and characterization, cells extracts, culture reagents, quality control strains, proteins and cell extracts. ATCC’s services include production and characterization, biorepository management, testing services, and deposit services. The organization offers custom testing services for mycoplasma detection and human cell line authentication. It serves research and life science industry. The organization also provides storage of biomaterials through its facility. ATCC is headquartered in Manassas, Virginia, the US.

ATCC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATCC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATCC, Medical Devices Deals, 2012 to YTD 2018 8
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ATCC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Horizon Discovery Enters Into Licensing Agreement With ATCC 10
ATCC Forms Joint Venture with ILSE 11
BioCision Enters Into Co-Development Agreement With ATCC 12
Licensing Agreements 13
Biomatrica Enters Into Licensing Agreement With ATCC For DNAstable And RNAstable Reagents 13
ATCC Enters into Licensing Agreement with Baylor College of Medicine 14
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 15
ATCC – Key Competitors 16
ATCC – Key Employees 17
ATCC – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Recent Developments 19
Strategy And Business Planning 19
Apr 21, 2017: ATCC Opens Doors to New High-Tech Biorepository in Gaithersburg, MD 19
Product News 20
Nov 20, 2017: ATCC develops novel in vitro model to investigate drug candidates for cancer metastasis 20
Other Significant Developments 21
Jul 10, 2018: ATCC launches new PCR-based Mycoplasma Detection Service 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
ATCC, Pharmaceuticals & Healthcare, Key Facts 2
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATCC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATCC, Medical Devices Deals, 2012 to YTD 2018 8
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Horizon Discovery Enters Into Licensing Agreement With ATCC 10
ATCC Forms Joint Venture with ILSE 11
BioCision Enters Into Co-Development Agreement With ATCC 12
Biomatrica Enters Into Licensing Agreement With ATCC For DNAstable And RNAstable Reagents 13
ATCC Enters into Licensing Agreement with Baylor College of Medicine 14
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 15
ATCC, Key Competitors 16
ATCC, Key Employees 17
ATCC, Joint Venture 18

List of Figures
ATCC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATCC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATCC, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[ATCC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ecsponent Limited (ECS):企業の財務・戦略的SWOT分析
    Ecsponent Limited (ECS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cherry Rocher Neyret Chavin SA:企業の戦略・SWOT・財務情報
    Cherry Rocher Neyret Chavin SA - Strategy, SWOT and Corporate Finance Report Summary Cherry Rocher Neyret Chavin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cymbet Corp:電力:M&Aディール及び事業提携情報
    Summary Cymbet Corp (Cymbet) is a clean technology company that offers energy storage solutions for microelectronic systems. The company’s products include EnerChip, EnerChip solid state batteries, EnerChip bare die, EnerChip RTC and evaluation kits. Its devices offers new concept in energy storage …
  • Precipio Inc (TBIO):企業の財務・戦略的SWOT分析
    Summary Precipio Inc (Precipio), formerly known as Transgenomic Inc, develops diagnostic tools. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. Precipio uses ICE COLD-P …
  • Vertu Motors Plc:企業のM&A・事業提携・投資動向
    Vertu Motors Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vertu Motors Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • LifeScan Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …
  • Business Connexion Group Limited:企業の戦略的SWOT分析
    Business Connexion Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Turkiye Petrol Rafinerileri AS (TUPRS):企業の財務・戦略的SWOT分析
    Turkiye Petrol Rafinerileri AS (TUPRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • New Brunswick Power Corporation:企業の戦略的SWOT分析
    New Brunswick Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Singapore Telecommunications Ltd:企業の戦略・SWOT・財務分析
    Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • MGP Ingredients Inc (MGPI):企業の財務・戦略的SWOT分析
    MGP Ingredients Inc (MGPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ashok Leyland Limited:企業のM&A・事業提携・投資動向
    Ashok Leyland Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ashok Leyland Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Dubai Islamic Bank P.J.S.C.:戦略・SWOT・企業財務分析
    Dubai Islamic Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Dubai Islamic Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Keikyu Corporation:企業の戦略・SWOT・財務情報
    Keikyu Corporation - Strategy, SWOT and Corporate Finance Report Summary Keikyu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tetra Tech Inc:企業の戦略・SWOT・財務分析
    Tetra Tech Inc - Strategy, SWOT and Corporate Finance Report Summary Tetra Tech Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Culture Landmark Investment Ltd:企業の戦略・SWOT・財務分析
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Enterome Bioscience SA-医療機器分野:企業M&A・提携分析
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • Wilson Vale:企業の戦略・SWOT・財務情報
    Wilson Vale - Strategy, SWOT and Corporate Finance Report Summary Wilson Vale - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Energiequelle GmbH-エネルギー分野:企業M&A・提携分析
    Summary Energiequelle GmbH (Energiequelle) is a renewable energy company that provides turnkey system services to wind, biogas, and solar energy projects. Its offerings include planning and construction services: identification of project site, negotiation, and construction of project; and grid conn …
  • Caesars Entertainment Corporation (CZR):企業の財務・戦略的SWOT分析
    Caesars Entertainment Corporation (CZR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆